Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.62 |
| ▸ | TYR | P14679 | 2/20 | 0.58 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.57 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.57 |
| ▸ | TYMP | P19971 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 4/20 | 0.53 |
| ▸ | HKDC1 | Q2TB90 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | TNNI3 | P19429 | 2/20 | 0.53 |
| ▸ | TNNT2 | P45379 | 2/20 | 0.53 |
| ▸ | TNNC1 | P63316 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4281885 | 0.88 | SLC5A2 (0.64) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL8654543 | 0.88 | SLC5A2 (0.64) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL8654092 | 0.88 | SLC5A2 (0.64) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL8659653 | 0.88 | SLC5A2 (0.64) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL28176940 | 0.88 | SLC5A2 (0.64) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL14164007 | 0.88 | SLC5A2 (0.64) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL244406 | 0.88 | SLC5A2 (0.64) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL29382560 | 0.88 | SLC5A2 (0.64) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL942732 | 0.86 | SLC28A3 (0.62) | SLC28A3TYRSLC5A1SLC5A2HIF1A | |
| SCHEMBL941049 | 0.84 | SLC28A3 (0.60) | SLC28A3TYRSLC5A1SLC5A2TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8268868-A | — | — | None | — | — | JP | disclosed |
| JP-8268871-A | — | — | None | — | — | JP | disclosed |
| JP-8268870-A | — | — | None | — | — | JP | disclosed |
| JP-8268869-A | — | — | None | — | — | JP | disclosed |
| JP-8268872-A | — | — | None | — | — | JP | disclosed |
| EP-1932514-B1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | EZAKI GLICO CO (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | EZAKI GLICO CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20110014141-A1 | TOPICAL AGENT FOR DERMATOLOGICAL USE | DSM IP ASSETS B.V. (NL) | 2011-01-20 | — | — | US | disclosed |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | EZAKI GLICO CO., LTD. (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1932514-A1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | Ezaki Glico Co., Ltd. (JP) | 2008-06-18 | — | — | EP | disclosed |
| EP-1859835-A2 | Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-D-glucopyranoside | PENTAPHARM Ltd. (CH) | 2007-11-28 | — | — | EP | disclosed |
| US-20030198610-A1 | Topical agent for dermatological use | DSM IP ASSETS B.V. (NL) | 2003-10-23 | — | — | US | disclosed |
| EP-1289489-A2 | TOPICAL AGENT FOR DERMATOLOGICAL USE CONTAINING 4-HYDROXYPHENYL-ALPHA-D-GLUCOPYRANOSIDE | PENTAPHARM Ltd. (CH) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001091715-A2 | TOPICAL AGENT FOR DERMATOLOGICAL USE CONTAINING 4-HYDROXYPHENYL-ALPHA-D-GLUCOPYRANOSIDE | PENTAPHARM LTD. (CH) | 2001-12-06 | — | — | WO | disclosed |
| EP-0649648-B1 | Skin whitening agents containing glycosides | SHISEIDO CO LTD (JP) | 2001-09-19 | — | — | EP | disclosed |
| JP-H08268871-A | COSMETIC | SHISEIDO CO LTD | 1996-10-15 | — | — | JP | disclosed |
| JP-H08268868-A | DERMAL PREPARATION FOR EXTERNAL USE | SHISEIDO CO LTD | 1996-10-15 | — | — | JP | disclosed |
| JP-H08268870-A | DERMAL PREPARATION FOR EXTERNAL USE | SHISEIDO CO LTD | 1996-10-15 | — | — | JP | disclosed |
| JP-H08268872-A | DERMAL PREPARATION FOR EXTERNAL USE | SHISEIDO CO LTD | 1996-10-15 | — | — | JP | disclosed |
| JP-H08268869-A | DERMAL PREPARATION FOR EXTERNAL USE | SHISEIDO CO LTD | 1996-10-15 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014141-A1 | TOPICAL AGENT FOR DERMATOLOGICAL USE | GALE, ALPP, UGGT1 | SLC28A3 2245/4885TYR 9/4885SLC5A1 1371/4885 |
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | SI, CUTA, CD44 | SLC28A3 1164/4885TYR 149/4885SLC5A1 723/4885 |
| US-20030198610-A1 | Topical agent for dermatological use | GALE, UGGT1, UGDH | SLC28A3 2040/4885TYR 6/4885SLC5A1 1242/4885 |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | CUTA, SI, CD44 | SLC28A3 977/4885TYR 113/4885SLC5A1 589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.